Immunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in rats

Journal of Trauma - Injury, Infection and Critical Care

Volumn 44, Issue 3, 1998, Pages 475-483

  Matsuda, Teishi ^a   Yamaguchi, Yasuo ^a   Matsumura, Fujio ^a   Akizuki, Eiji ^a   Okabe, Kazutoshi ^a   Liang, Jian ^a   Ohshiro, Hajime ^a   Ichiguchi, Osamu ^a   Yamada, Shinwa ^b   Mori, Katsutaka ^a   Ogawa, Michio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Azathioprine; Cyclosporine; Cytokine induced neutrophil chemoattractant (CINC); Liver; Rapamycin; Rat; Reperfusion injury; Tacrolimus

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; MYELOPEROXIDASE; RAPAMYCIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0031902388     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199803000-00009     Document Type: Article

References (61)

1. Borel JF, Feurer C, Gubler JU, Stahelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976;6:468-475.
2. Fruman DA, Klee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc Natl Acad Sci USA. 1992;89:3686-3690.
3. Sigal NH, Dumont FJ. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol. 1992;10:519-560.
4. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury: modulating effects of FK506 and cyclosporine. Transplantation. 1993;55:1265-1272.
5. Puglisi RN, Strande L, Santos M, Schulte G, Hewitt CW, Whalen TV. Beneficial effects of cyclosporine and rapamycin in small bowel ischemic injury. J Surg Res. 1996; 65:115-118.
6. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J. 1990;4:3355-3359.
7. Poggetti RS, Moore FA, Moore EE, Bensard DD, Anderson BO, Benerjee A. Liver injury is a reversible neutrophil-mediated event following gut ischemia. Arch Surg. 1992; 127:175-179.
8. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989;84:1045-1049.
9. Watanabe K, Kinoshita S, Nakagawa H. Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelial cell line of normal rat kidney (NRK-52E cell). Biochem Biophys Res Commun. 1989;161:1093-1099.
10. Watanabe K, Suematsu M, Iida M, et al. Effect of rat CINC/ gro, a member of interleukin-8 family, on leukocytes in microcirculation of the rat mesentery. Exp Mol Pathol. 1992; 56:60-69.
11. Watanabe K, Konishi K, Fujioka M, Kinoshita S, Nakagawa H. The neutrophil chemoattractant produced by the rat kidney epithelial cell line NRK-52E is a protein related to the KC/gro protein. J Biol Chem. 1989;264:19559-19563.
12. 2+ signals and immunosuppression. Nature. 1996; 383:837-840.
13. Pazderka F, Enns J, Batiuk TD, Halloran PF. The functional consequences of partial calcineurin inhibition in human peripheral blood mononuclear leukocytes. Transplant Immunol. 1996;4:23-31.
14. National Institutes of Health. Guide for the Care and Use of Laboratory Animals. Bethesda, Md: Public Health Service; 1985. NIH publication 86-23.
15. Sakr MF, McClain CJ, Gavaler JS, Zetti GM, Starzl TE, Van Thiel DH. FK506 pre-treatment is associated with reduced levels of tumor necrosis factor and interleukin 6 following hepatic ischemia/reperfusion. J Hepatol. 1993; 17:301-307.
16. Nakagawa H, Ikesue A, Kato H, et al. Changes in the levels of rat interleukin 8/CINC and gelatinase in the exudate of carrageenan-induced inflammation in rats. J Pharmacobio-Dyn. 1992;15:461-466.
17. Berry MN, Friend DS. High yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structure study. J Cell Biol. 1969;43:506-520.
18. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 1976;13:29-83.
19. Gandhi CR, Stephenson K, Olson MS. A comparative endothelin- and platelet- activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells. Biochem J. 1992;281:485-492.
20. Fustafa SB, Gandhi CR, Harvey SAK, Olson MS. Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells. Hepatology. 1994;21:545-553.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
22. Konishi K, Takata Y, Yamamoto M, et al. Structure of the gene coding rat neutrophil chemo-attractant Gro. Gene. 1993;126:285-286.
23. Matsuno K, Ezaki T, Kotani M. Splenic outer periarterial lymphoid sheath (PALS): an immunoproliferative microenvironment constituted by antigen-laden marginal metallophils and ED2-positive macrophage in the rat. Cell Tissue Res. 1989;257:459-470.
24. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2, and ED3. Immunology. 1985;54:589-599.
25. Komatsu H, Koo A, Ghadishah E, et al. Neutrophil accumulation in ischemic reperfused rat liver: evidence for a role for superoxide free radicals. Am J Physiol. 1992; 262:G669-G676.
26. Suzuki K, Ota J, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem. 1983;132:345-352.
27. Williams RN, Delawere NA, Paterson CA. Inactivation of catalase with 3-amino-1,2,4-triazole: an indirect irreversible mechanism. Biochem Pharmacol. 1985;34:3386-3389.
28. Andrews PC, Krinsky NI. Human myeloperoxidase and hemi-myeloperoxidase. Methods Enzymol. 1986;132:369-378.
29. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol. 1986;251:G567-G574.
30. Yam LT, Li CY, Crosby WH. Cytochemical identification of monocytes and granulocytes. Am J Pathol. 1971;55:283-290.
31. Hisama N, Yamaguchi Y, Ishiko T, et al. Kupffer cell production of cytokine-induced neutrophil chemoattractant (CINC) following ischemia/reperfusion injury in rats. Hepatology. 1996;24:1193-1198.
32. Adams DH, Wang LF, Neuberger JM, Elias E. Inhibition of leukocyte chemotaxis by immunosuppressive agents: specific inhibition of lymphocyte chemotaxis by cyclosporine. Transplantation. 1990;50:845-850.
33. Adams DH, Liu O. FK560 inhibits human lymphocyte migration and the production of chemotactic factors in liver allograft recipients. Hepatology. 1996;23:1476-1483.
34. Weibaum DL, Kaplan SS, Zdziarski U, Rinaldo CR, Schroeder KK. Human polymorphonuclear leukocyte interaction with cyclosporin A. Infect Immun. 1984;43:791-794.
35. Janco RL, English D. Cyclosporine and human neutrophil function. Transplantation. 1983;35:501-503.
36. Kubes P, Hunter J, Granger DN. Effects of cyclosporin A and FK506 on ischemia/reperfusion-induced neutrophil infiltration in the cat. Dig Dis Sci. 1991;36:1469-1472.
37. Colletti LM, Burtch GD, Remick DG, et al. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation. 1990;49:268-272.
38. Schlayer HJ, Laaff H, Peters T, et al. Involvement of tumor necrosis factor in endotoxin-triggered neutrophil adherence to sinusoidal endothelial cells of mouse liver and its modulation in acute phase. J Hepatol. 1988;7:239-249.
39. Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stent D. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med. 1986;163:1363-1375.
40. Castillo M, Toledo-Pereya LH, Prough D, Sharpiro E, Gordon D, Choudhury S. Effective timing of allopurinol administration in the ischemic liver. Transplantation. 1989; 47:727-730.
41. Atalla SL, Toledo-Pereya LH, MacKenzie GH, Cederna JP. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation. 1985;40:584-590.
42. Romani F, Vertemati M, Frangi M, et al. Effect of superoxide dismutase on liver ischemia-reperfusion injury in the rat: a biochemical monitoring. Eur Surg Res. 1988; 20:335-340.
43. Holschermann H, Durfeld F, Maus U, et al. Cyclosporine A inhibits tissue factor expression in monocytes/macrophages. Blood. 1996;88:3837-3845.
44. Kawai M, Nishikomori R, Jung EY, et al. Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. J Immunol. 1995;154:2333-2341.
45. Blackwell TS, Holden EP, Blackwell TR, DeLarco JE, Christman JW. Cytokine-induced neutrophil chemoattractant mediates neutrophilic alveolitis in rats: association with nuclear factor kB activation. Am J Respir Cell Mol Biol. 1994;11:464-472.
46. Ohtsuka T, Kubota A, Hirano T, et al. Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NF-kB activation. J Biol Chem. 1996;271:1651-1659.
47. Suthanthiran M, Morris RE, Strom TB. Immunosuppressants: cellular and molecular mechanisms of action. Am J Kidney Dis. 1996;28:159-172.
48. Hughes SE, Gruber SA. New immunosuppressive drugs in organ transplantation. J Clin Pharmacol. 1996;36:1081-1092.
49. Kawano K, Kim YI, Ono M, Goto S, Kai T, Kobayashi M. Evidence that both cyclosporine and azathioprine prevent warm ischemia reperfusion injury to the rat liver. Transplant Int. 1993;6:330-336.
50. Fruman DA, Burakoff SJ, Bierer BE. Immunophilins in protein folding and immunosuppression. FASEB J. 1994; 8:391-400.
51. Frantz B, Nordby EC, Bren G, et al. Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B. EMBO J. 1994;13:861-870.
52. Kawamura A, Su MS. Interaction of FKBP12-FK506 with calcineurin A at the B subunit-binding domain. J Biol Chem. 1995;270:15463-15466.
53. Milan D, Griffith J, Su M, Price ER, McKeon F. The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation. Cell. 1994;79:437-447.
54. 2+ and reactive oxygen intermediates as messengers. FEBS Lett. 1996;329:129-136.
55. Pahl HL, Sester M, Burgert HG, Baeuerle PA. Activation of transcription factor NF-kB by the adenovirus E3/19K protein requires its ER retention. J Cell Biol. 1996;132:511-522.
56. Shatrov VA, Lehmann V, Chouaib S. Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-kappa B in U937 cells. Biochem Biophys Res Commun. 1997;234:121-124.
57. 2+ influx: functional synergy between Raf and calcineurin. J Immunol. 1996;157:5277-5283.
58. 2+ influx. Cell. 1995;83:463-472.
59. Cameron AM, Steiner JP, Sabatini DM, Kaplin AI, Walensky LO, Snyder SH. Immunophilin FK506 binding protein associated with inositol 1,4,5- triphosphate receptor modulates calcium flux. Proc Natl Acad Sci USA. 1995; 92:1784-1788.
60. 2+-modulating cyclophilin ligand modulates calcium influx signaling in T lymphocytes. J Biol Chem. 1996;271:8549-8552.
61. Bram RJ, Crabtree GR. Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. Nature. 1994; 371:355-358.